<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="preparation">Obesity and related disorders are widely perceived by both the public and the scientific community as a major and growing threat to global human health ;</segment>
<segment id="3" parent="1002" relname="joint">more than 2 billion people worldwide are currently overweight or obese ,</segment>
<segment id="4" parent="1004" relname="span">and obesity is associated with an increased hazard for a range of ailments ,</segment>
<segment id="5" parent="4" relname="elaboration">including type-2 diabetes , cardiovascular diseases and hypertension , multiple cancer types , chronic inflammatory diseases , dementia , and neurodegenerative diseases .</segment>
<segment id="6" parent="1002" relname="joint">All these complications lead to a shortened life expectancy</segment>
<segment id="7" parent="1002" relname="joint">and have a high economic impact on healthcare systems .</segment>
<segment id="8" parent="1009" relname="span">Lifestyle changes</segment>
<segment id="9" parent="8" relname="elaboration">( such as diet modification , physical activity , and behavioral interventions )</segment>
<segment id="10" parent="1008" relname="same_unit">are the cornerstones of obesity treatment</segment>
<segment id="11" parent="1010" relname="joint">but maintaining a healthy lifestyle is often perceived as challenging .</segment>
<segment id="12" parent="1010" relname="joint">Alternatively , pharmacotherapy and bariatric surgery represent more “ aggressive ” interventions ,</segment>
<segment id="13" parent="1013" relname="span">and are applicable only</segment>
<segment id="14" parent="13" relname="condition">if the problem is severe .</segment>
<segment id="15" parent="1015" relname="span">Current pharmacotherapy for obesity relies on a few drugs</segment>
<segment id="16" parent="15" relname="elaboration">that are approved only for patients with BMI &gt; 30 .</segment>
<segment id="17" parent="1019" relname="span">With the only exception of orlistat</segment>
<segment id="18" parent="17" relname="elaboration">( which decreases fat absorption</segment>
<segment id="19" parent="1019" relname="means">by inhibiting lipases ) ,</segment>
<segment id="20" parent="1021" relname="span">most of these drugs act through the central nervous system</segment>
<segment id="21" parent="20" relname="purpose">to reduce food intake</segment>
<segment id="22" parent="1021" relname="elaboration">( via reduction of appetite or enhancement of satiety ) .</segment>
<segment id="23" parent="1023" relname="span">However , the use of these treatments may lead to severe adverse effects</segment>
<segment id="24" parent="23" relname="elaboration">and a long-term prescription is usually not recommended .</segment>
<segment id="25" parent="1026" relname="span">A nutraceutical approach could be a useful supporting tool</segment>
<segment id="26" parent="25" relname="purpose">to treat overweight people ,</segment>
<segment id="27" parent="1026" relname="cause">since the use of natural compounds offers clear advantages over drug treatments in terms of adverse side effects , suitability for chronic treatments , marketability , and safety .</segment>
<segment id="28" parent="1029" relname="span">Here we focus our attention on pterostilbene</segment>
<segment id="29" parent="28" relname="elaboration">( Pt ; 3,5-dimethylresveratrol ) ,</segment>
<segment id="30" parent="1030" relname="span">an analogue of resveratrol</segment>
<segment id="31" parent="30" relname="elaboration">that differs from the latter for the presence of two methyl groups .</segment>
<segment id="32" parent="1016" relname="joint">Its increased lipophilicity accounts for its ability to reach higher tissue levels in comparison to resveratrol ’s .</segment>
<segment id="33" parent="1016" relname="joint">Moreover , there is no concern about its safety .</segment>
<segment id="34" parent="1034" relname="span">Pterostilbene has already been shown to have positive effects</segment>
<segment id="35" parent="34" relname="elaboration">in combating obesity and related disorders .</segment>
<segment id="36" parent="1039" relname="span">In rat models of obesity , Pt reduces fat accumulation and ameliorates liver steatosis</segment>
<segment id="37" parent="36" relname="elaboration">modulating lipolysis , lipogenesis , fatty acid oxidation ,</segment>
<segment id="38" parent="1038" relname="same_unit">improves glycemic control</segment>
<segment id="39" parent="1038" relname="means">by modulating glycolysis , gluconeogenesis , and glucose uptake ,</segment>
<segment id="40" parent="1040" relname="joint">increases thermogenic markers in brown adipose tissue ,</segment>
<segment id="41" parent="1040" relname="joint">and induces changes in the gut microbiota towards a healthier composition .</segment>
<segment id="42" parent="1042" relname="span">Furthermore , Pt exerts its beneficial effects</segment>
<segment id="43" parent="42" relname="elaboration">combating adipose tissue inflammation .</segment>
<segment id="44" parent="1045" relname="span">An interesting therapeutic target</segment>
<segment id="45" parent="1046" relname="span">for treating obesity and metabolic syndrome is represented by beige</segment>
<segment id="46" parent="45" relname="elaboration">( or brite , i.e. , brown-in-white )</segment>
<segment id="47" parent="1044" relname="same_unit">adipocytes .</segment>
<segment id="48" parent="1049" relname="span">These cells are an inducible form of thermogenic adipocytes</segment>
<segment id="49" parent="1050" relname="span">residing in subcutaneous white adipose tissue</segment>
<segment id="50" parent="49" relname="restatement">( WAT )</segment>
<segment id="51" parent="1016" relname="joint">and are also found in human adults .</segment>
<segment id="52" parent="1053" relname="preparation">Beige adipocytes can derive from white adipocyte trans differentiation and from the differentiation of adipogenic progenitor cells .</segment>
<segment id="53" parent="1053" relname="joint">They express a set of beige-specific genes , such as Cited1 and Tbx1 ,</segment>
<segment id="54" parent="1055" relname="span">but also have similarities with brown adipocytes ,</segment>
<segment id="55" parent="1056" relname="span">including abundant mitochondria , multilocular lipid droplets and expression of brown-specific genes such as uncoupling protein 1</segment>
<segment id="56" parent="55" relname="restatement">( UCP1 )</segment>
<segment id="57" parent="1053" relname="joint">and Cidea ;</segment>
<segment id="58" parent="1058" relname="span">similar to brown adipocytes ,</segment>
<segment id="59" parent="58" relname="elaboration">they are able to dissipate energy as heat .</segment>
<segment id="60" parent="1062" relname="span">Induction of beige adipocytes</segment>
<segment id="61" parent="60" relname="elaboration">( i.e. , WAT browning )</segment>
<segment id="62" parent="1063" relname="span">can be induced by environmental or physiological stimuli</segment>
<segment id="63" parent="62" relname="elaboration">( such as cold exposure , physical activity , or thyroid hormones ) ,</segment>
<segment id="64" parent="1065" relname="span">but also pharmacologically</segment>
<segment id="65" parent="64" relname="elaboration">( for example , with PPAR agonists ) ,</segment>
<segment id="66" parent="1066" relname="span">and could prevent or combat obesity</segment>
<segment id="67" parent="66" relname="means">by increasing energy consumption through non-shivering thermogenesis .</segment>
<segment id="68" parent="1068" relname="span">Various phytochemicals have been reported</segment>
<segment id="69" parent="68" relname="purpose">to promote fat browning .</segment>
<segment id="70" parent="1070" relname="span">The aim of this study was to investigate the ability of Pt to do it in WAT .</segment>
<segment id="71" parent="1071" relname="span">Its effects were first assayed on cultured 3T3-L1 adipocytes , and then in a mouse model of diet-induced obesity .</segment>
<segment id="72" parent="1072" relname="joint">To take into account possible gender-specific differences ,</segment>
<segment id="73" parent="1073" relname="span">both females and males were included in our experimental groups ;</segment>
<segment id="74" parent="1074" relname="span">a 30 week-long treatment was performed ,</segment>
<segment id="75" parent="74" relname="purpose">to highlight long-term effects of a chronic Pt supplementation .</segment>
<segment id="76" parent="1077" relname="attribution">We found</segment>
<segment id="77" parent="1077" relname="span">that Pt diminished body weight gain</segment>
<segment id="78" parent="77" relname="elaboration">induced by a high-fat diet regimen ;</segment>
<segment id="79" parent="1016" relname="joint">also , glucose homeostasis was partially preserved , at least up to week 18 .</segment>
<segment id="80" parent="1016" relname="joint">Interestingly , Pt was able to induce WAT browning ,</segment>
<segment id="81" parent="1080" relname="span">leading to an increase in the transcription of beige- and brown-related genes and of UCP1 protein levels ,</segment>
<segment id="82" parent="81" relname="elaboration">which , however , did not achieve significance .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1004" type="span" parent="1002" relname="joint"/>
<group id="1007" type="span" parent="1002" relname="joint"/>
<group id="1008" type="multinuc" parent="1010" relname="preparation"/>
<group id="1009" type="span" parent="1008" relname="same_unit"/>
<group id="1010" type="multinuc" parent="1007" relname="span"/>
<group id="1013" type="span" parent="1010" relname="joint"/>
<group id="1014" type="span" parent="1010" relname="joint"/>
<group id="1015" type="span" parent="1016" relname="preparation"/>
<group id="1016" type="multinuc" parent="1014" relname="span"/>
<group id="1017" type="multinuc" parent="1016" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="same_unit"/>
<group id="1019" type="span" parent="1018" relname="span"/>
<group id="1020" type="span" parent="1017" relname="same_unit"/>
<group id="1021" type="span" parent="1020" relname="span"/>
<group id="1023" type="span" parent="1016" relname="joint"/>
<group id="1025" type="span" parent="1016" relname="joint"/>
<group id="1026" type="span" parent="1025" relname="span"/>
<group id="1028" type="multinuc" parent="1016" relname="joint"/>
<group id="1029" type="span" parent="1028" relname="same_unit"/>
<group id="1030" type="span" parent="1028" relname="same_unit"/>
<group id="1034" type="span" parent="1016" relname="joint"/>
<group id="1036" type="multinuc" parent="1016" relname="joint"/>
<group id="1037" type="span" parent="1036" relname="same_unit"/>
<group id="1038" type="multinuc" parent="1037" relname="span"/>
<group id="1039" type="span" parent="1038" relname="same_unit"/>
<group id="1040" type="multinuc" parent="1036" relname="same_unit"/>
<group id="1042" type="span" parent="1016" relname="joint"/>
<group id="1044" type="multinuc" parent="1016" relname="joint"/>
<group id="1045" type="span" parent="1044" relname="same_unit"/>
<group id="1046" type="span" parent="44" relname="elaboration"/>
<group id="1049" type="span" parent="1016" relname="joint"/>
<group id="1050" type="span" parent="48" relname="elaboration"/>
<group id="1052" type="span" parent="1016" relname="joint"/>
<group id="1053" type="multinuc" parent="1052" relname="span"/>
<group id="1055" type="span" parent="1053" relname="joint"/>
<group id="1056" type="span" parent="54" relname="elaboration"/>
<group id="1058" type="span" parent="1053" relname="joint"/>
<group id="1061" type="multinuc" parent="1016" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="same_unit"/>
<group id="1063" type="span" parent="1061" relname="same_unit"/>
<group id="1065" type="span" parent="1016" relname="joint"/>
<group id="1066" type="span" parent="1016" relname="joint"/>
<group id="1068" type="span" parent="1016" relname="joint"/>
<group id="1070" type="span" parent="1016" relname="joint"/>
<group id="1071" type="span" parent="70" relname="elaboration"/>
<group id="1072" type="multinuc" parent="71" relname="purpose"/>
<group id="1073" type="span" parent="1072" relname="joint"/>
<group id="1074" type="span" parent="73" relname="elaboration"/>
<group id="1076" type="span" parent="1016" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="span"/>
<group id="1080" type="span" parent="1016" relname="joint"/>
	</body>
</rst>
